MedPath
FDA Product

ARZERRA

Product approved by U.S. Food and Drug Administration (US)

Basic Information

ARZERRA

0078-0669

Regulatory Information

0078-0669

BLA125326

C73585

January 19, 2016

USA

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. ARZERRA (ofatumumab) injection, for intravenous useInitial U.S. Approval: 2009

HUMAN PRESCRIPTION DRUG LABEL

9

Company Information

002147023

Active Ingredients

OFATUMUMAB

Quantity: 20 mg in 1 mL

Code: M95KG522R0

Class Code: ACTIB

HYDROCHLORIC ACID

Code: QTT17582CB

Class Code: IACT

POLYSORBATE 80

Code: 6OZP39ZG8H

Class Code: IACT

ARGININE

Code: 94ZLA3W45F

Class Code: IACT

EDETATE DISODIUM

Code: 7FLD91C86K

Class Code: IACT

SODIUM ACETATE

Code: 4550K0SC9B

Class Code: IACT

SODIUM CHLORIDE

Code: 451W47IQ8X

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

Active Moieties

OFATUMUMAB

Code: M95KG522R0

© Copyright 2025. All Rights Reserved by MedPath